Skip to main content
USNZ logo
USNZ
(NYSEARCA)
Xtrackers Net Zero Pathway Paris Aligned US Equity ETF
$48.96-- (--)
Loading... - Market loading

USNZ ETF: Xtrackers Net Zero Pathway Paris Aligned US Equity ETF - Price, Holdings & Analysis

Xtrackers Net Zero Pathway Paris Aligned US Equity ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$48.96 - $48.96
52-Week High$49.26
52-Week Low$38.98
Open$48.96
Volume100
Average Volume (3M)477
Assets (AUM)288.02M
Expense Ratio0.10%
Total Holdings311
Inception DateJun 28, 2022
1 Day Change-0.27%
1 Month Change0.23%
6 Month Change15.30%
YTD Change13.26%
1 Year Change19.33%
52-Week Change19.33%
50-Day MA$47.95
200-Day MA$44.88
RSI56.76
Stochastic %K84.09
Stochastic %D72.81
Annual Dividend$0.64
Dividend Yield1.32%
Last Dividend Ex-DateSep 26, 2026
Dividend Growth YoY47.03%
Years Dividend Growth3

Frequently Asked Questions About Xtrackers Net Zero Pathway Paris Aligned US Equity ETF

What is the current price of USNZ?

The latest USNZ price is $48.96. The 52-week range is $38.98–$49.26. USNZ has returned 19.3% over the past 52 weeks.

What is the expense ratio for USNZ?

USNZ's annual expense ratio is 0.10%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does USNZ pay dividends?

Yes, USNZ pays a 1.32% dividend yield. The last ex-dividend date was 2026-09-26. View full dividend history in the Dividends section.

What are the top holdings of USNZ?

USNZ's largest holdings are NVIDIA Corporation (9.8%), Apple Inc (9.4%), Microsoft Corporation (5.7%) (combined weight: 24.9%). The fund holds 311 total positions. View the complete portfolio breakdown in the Holdings section.

How does USNZ compare to similar ETFs?

Compare USNZ (0.10% expense ratio, $288M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.